• By: yuka.osada
• On: May 14, 2025

Japan’s Legacy in Orphan Drug Development

• By: yuka.osada
• On: April 23, 2025

FDA’s QIDP Designation: The Game-Changer in Antimicrobial Drug Innovation

• By: yuka.osada
• On: April 16, 2025

RMAT-The Regulatory Catalyst for Accelerating Regenerative Medicine Therapies

• By: yuka.osada
• On: February 13, 2025

FDA Accelerated Programs in Drug Development

• By: blaadmin
• On: January 23, 2025

US Agent for FDA Regulated Product Applications